Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER GALLAGHER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1467430579
CMS profile
1059838
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$12,283.14

19 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER GALLAGHER

NPI 1467430579 · CMS profile ID 1059838

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467430579?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER GALLAGHER, NPI 1467430579, CMS profile ID 1059838. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467430579?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CHRISTOPHER GALLAGHER, NPI 1467430579, CMS profile ID 1059838. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467430579?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CHRISTOPHER GALLAGHER, NPI 1467430579, CMS profile ID 1059838, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–19 of 19 matching records. This page contains 19 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1467430579?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

19 matching records · $12,283.14 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 19 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–19 of 19.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $27.4611/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141867589 CMS
Daiichi Sankyo Inc. $4,920.0010/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423835 CMS
Merck Sharp & Dohme LLC $18.9410/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141691496 CMS
Merck Sharp & Dohme LLC $29.8210/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141691500 CMS
AstraZeneca Pharmaceuticals LP $1,370.0010/17/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104616712 CMS
Daiichi Sankyo Inc. $29.2410/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423829 CMS
Daiichi Sankyo Inc. $61.6410/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423833 CMS
Daiichi Sankyo Inc. $114.4810/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423831 CMS
AstraZeneca Pharmaceuticals LP $72.2509/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105313048 CMS
AstraZeneca Pharmaceuticals LP $18.6509/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105400314 CMS
Aveo Pharmaceuticals, Inc. $33.0309/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143475363 CMS
Alexion Pharmaceuticals, Inc. $26.7408/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093956877 CMS
Eli Lilly and Company $2,400.0007/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136100158 CMS
AstraZeneca Pharmaceuticals LP $250.0007/02/2024 Grant No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104504270 CMS
Daiichi Sankyo Inc. $2,750.0005/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423863 CMS
Daiichi Sankyo Inc. $17.4205/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423857 CMS
Daiichi Sankyo Inc. $10.0005/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423859 CMS
Daiichi Sankyo Inc. $103.3205/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089423861 CMS
Merck Sharp & Dohme LLC $30.1505/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141691498 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,596.91 4
PY2020 $11,770.55 12
PY2021 $14,659.83 14
PY2022 $32,572.39 26
PY2023 $30,914.33 25
PY2024 $12,283.14 19
PY2025 $3,812.19 26

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $134,677.68 26
PY2024 Principal investigator $192,960.63 22
PY2023 Recipient $109.20 1
PY2023 Principal investigator $287,719.82 33
PY2022 Principal investigator $223,087.49 47
PY2021 Recipient $2,220.00 4
PY2021 Principal investigator $184,110.05 25
PY2020 Principal investigator $291,681.40 53
PY2019 Principal investigator $138,556.60 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $6,850.00 05/14/2025 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INST
A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candidates for PD 1/PD L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer No dispute reported 06/30/2026 1185539497
Principal investigator 1 Daiichi Sankyo Inc. $6,600.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372162
Principal investigator 1 Daiichi Sankyo Inc. $500.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372164
Principal investigator 1 Daiichi Sankyo Inc. $17,250.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372166
Principal investigator 1 Daiichi Sankyo Inc. $4,500.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372168
Principal investigator 1 Daiichi Sankyo Inc. $4,550.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372170
Principal investigator 1 Daiichi Sankyo Inc. $1,500.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372172
Principal investigator 1 Daiichi Sankyo Inc. $6,525.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372174
Principal investigator 1 Daiichi Sankyo Inc. $2,535.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372176
Principal investigator 1 Daiichi Sankyo Inc. $4,056.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372178
Principal investigator 1 Daiichi Sankyo Inc. $12,450.00 04/11/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372180
Principal investigator 1 Daiichi Sankyo Inc. $1,500.00 03/21/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372142
Principal investigator 1 Daiichi Sankyo Inc. $1,300.00 03/21/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372144
Principal investigator 1 Daiichi Sankyo Inc. $6,600.00 03/21/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372146
Principal investigator 1 Daiichi Sankyo Inc. $500.00 03/21/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372148
Principal investigator 1 Daiichi Sankyo Inc. $500.00 03/21/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372150
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $12,500.00 02/13/2025 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE INC
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer No dispute reported 06/30/2026 1233740626
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,500.00 02/13/2025 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE INC
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer No dispute reported 06/30/2026 1233740628
Principal investigator 1 Daiichi Sankyo Inc. $15,800.00 01/27/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372136
Principal investigator 1 Daiichi Sankyo Inc. $5,100.00 01/27/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372138
Principal investigator 1 Daiichi Sankyo Inc. $12,450.00 01/27/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U301 No dispute reported 06/30/2026 1223372140
Principal investigator 1 Daiichi Sankyo Inc. $96.00 01/27/2025 Non-covered Recipient Entity
Medstar Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372154
Principal investigator 1 Daiichi Sankyo Inc. $160.00 01/27/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372156
Principal investigator 1 Daiichi Sankyo Inc. $160.00 01/27/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372158
Principal investigator 1 Daiichi Sankyo Inc. $160.00 01/27/2025 Non-covered Recipient Entity
MedStar Health Research Institute
DS8201-A-U302 No dispute reported 06/30/2026 1223372160
Principal investigator 1 AstraZeneca Pharmaceuticals LP $8,035.68 01/15/2025 Non-covered Recipient Entity
MEDSTAR HEALTH RESEARCH INSTITUTE INC
A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candidates for PD 1/PD L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer No dispute reported 06/30/2026 1185539499